Physician profile
Anna Braddock
NPI 1578205092
$3,350.93
in general payments reported to CMS, 2019-2025
20 companies · $1,310 in 2025
The $1,310 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,536 · 2024: $505 · 2025: $1,310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,591 · Travel and Lodging: $1,575 · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,591.08 |
| Travel and Lodging | $1,574.87 |
| Education | $184.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,345.25 | 2023-2024 | Axonics, Bulkamid |
| Intuitive Surgical, INC. | $667.15 | 2025 | |
| Sumitomo Pharma America, INC. | $195.32 | 2025 | Gemtesa |
| Astellas Pharma US INC | $184.98 | 2023-2024 | |
| Coloplast Corp | $141.43 | 2024 | |
| Abbvie INC. | $110.55 | 2024-2025 | |
| Boston Scientific Corporation | $104.01 | 2025 | General - Kidney Stone Disease |
| Terumo Medical Corporation | $98.28 | 2024 | Glidesheath Slender |
| Teleflex LLC | $74.37 | 2025 | Urolift, Barrigel |
| Ferring Pharmaceuticals INC. | $73.15 | 2025 | Adstiladrin |
| Tolmar, INC. | $66.80 | 2023-2024 | |
| Olympus America INC. | $60.63 | 2025 | Itind System |
| Telix Pharmaceuticals | $41.77 | 2023-2025 | Illuccix |
| Astrazeneca Pharmaceuticals Lp | $32.02 | 2023 | Lynparza |
| Immunitybio, INC. | $30.87 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $30.38 | 2024 | |
| Corcept Therapeutics | $24.99 | 2024 | Korlym |
| Progenics Pharmaceuticals, INC. | $24.67 | 2025 | |
| Janssen Biotech, INC. | $22.56 | 2023 | Erleada |
| Pacira Pharmaceuticals Incorporated | $21.75 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Braddock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.